Search

everythinglearnresearchcommunity

for

Search:↓

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Cyclosporin doesn't stop hair loss.

Different lab conditions and light treatment methods change how human skin cells respond to light therapy.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

The article suggests that patients with Frontal Fibrosing Alopecia may have more contact allergies, but it doesn't prove that allergies cause the condition.

Epidermal keratinocytes start wound healing and inflammation after schistosome infection.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

The document explains various skin conditions and their treatments.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

NOC-4 extract promotes black hair and hair growth effectively.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Somatostatin may help protect hair follicles from immune attacks.

Regenerative therapies show promise for treating vitiligo and alopecia areata.